• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Individuals with dementia and populations with dementia.

作者信息

Shaaban C Elizabeth

机构信息

Department of Epidemiology, School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA.

Alzheimer's Disease Research Center, University of Pittsburgh, Pittsburgh, PA, USA.

出版信息

Cereb Circ Cogn Behav. 2024 Apr 10;6:100221. doi: 10.1016/j.cccb.2024.100221. eCollection 2024.

DOI:10.1016/j.cccb.2024.100221
PMID:39071737
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11273090/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62f9/11273090/935270fe8ba5/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62f9/11273090/935270fe8ba5/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62f9/11273090/935270fe8ba5/gr1.jpg

相似文献

1
Individuals with dementia and populations with dementia.患有痴呆症的个体及痴呆症群体。
Cereb Circ Cogn Behav. 2024 Apr 10;6:100221. doi: 10.1016/j.cccb.2024.100221. eCollection 2024.
2
Comparing clinical trial population representativeness to real-world populations: an external validity analysis encompassing 43 895 trials and 5 685 738 individuals across 989 unique drugs and 286 conditions in England.比较临床试验人群代表性与真实世界人群：一项涵盖英国989种独特药物和286种病症的43895项试验及5685738名个体的外部有效性分析。
Lancet Healthy Longev. 2022 Oct;3(10):e674-e689. doi: 10.1016/S2666-7568(22)00186-6. Epub 2022 Sep 20.
3
Dementia in a tribal landlocked elderly population at high altitude: What explains the lower prevalence?内陆高海拔地区部落老年人群中的痴呆症：为何患病率较低？
J Neurosci Rural Pract. 2016 Jul-Sep;7(3):419-22. doi: 10.4103/0976-3147.182775.
4
New cases of dementia are rising in elderly populations in Wales, UK.英国威尔士老年人群体中痴呆症新发病例正在上升。
J Neurol Sci. 2023 Aug 15;451:120715. doi: 10.1016/j.jns.2023.120715. Epub 2023 Jun 19.
5
Dementia in older minority populations. Issues of prevalence, diagnosis, and treatment.老年少数族裔人群中的痴呆症。患病率、诊断及治疗问题。
Am J Geriatr Psychiatry. 1998 Spring;6(2 Suppl 1):S19-25. doi: 10.1097/00019442-199821001-00003.
6
Dementia and Cognitive Impairment Prevalence and Associated Factors in Indigenous Populations: A Systematic Review.原住民群体中痴呆症和认知障碍的患病率及相关因素：一项系统综述。
Alzheimer Dis Assoc Disord. 2016 Jul-Sep;30(3):281-7. doi: 10.1097/WAD.0000000000000140.
7
Identifying risk for dementia across populations: A study on the prevalence of dementia in tribal elderly population of Himalayan region in Northern India.识别不同人群的痴呆风险：关于印度北部喜马拉雅地区部落老年人口痴呆患病率的研究。
Ann Indian Acad Neurol. 2013 Oct;16(4):640-4. doi: 10.4103/0972-2327.120494.
8
Health and social correlates of dementia in oldest-old Mexican-origin populations.墨西哥裔高龄人群中痴呆症的健康和社会关联因素
Alzheimers Dement (N Y). 2020 Dec 16;6(1):e12105. doi: 10.1002/trc2.12105. eCollection 2020.
9
Is dementia differentially distributed? A study on the prevalence of dementia in migrant, urban, rural, and tribal elderly population of himalayan region in northern India.痴呆症的分布是否存在差异？印度北部喜马拉雅地区移民、城市、农村和部落老年人口中痴呆症患病率的研究。
N Am J Med Sci. 2014 Apr;6(4):172-7. doi: 10.4103/1947-2714.131243.
10
Evaluating the effects of a physical activity on agitation and wandering (PAAW) experienced by individuals living with a dementia in care homes.评估体育活动对养老院中患有痴呆症的个体所经历的激越和徘徊行为（PAAW）的影响。
J Res Nurs. 2018 May;23(2-3):125-138. doi: 10.1177/1744987118756479. Epub 2018 Mar 14.

引用本文的文献

1
Digital Therapeutics for Cognitive Impairment: Exploring Innovations, Challenges, and Future Prospects.用于认知障碍的数字疗法：探索创新、挑战与未来前景
J Med Internet Res. 2025 Jun 12;27:e73689. doi: 10.2196/73689.

本文引用的文献

1
Population-level interventions for the primary prevention of dementia: a complex evidence review.痴呆症一级预防的人群层面干预措施：一项复杂的证据综述
EClinicalMedicine. 2024 Mar 10;70:102538. doi: 10.1016/j.eclinm.2024.102538. eCollection 2024 Apr.
2
Estimated effects of amyloid reduction on cognitive change: A Bayesian update across a range of priors.预估淀粉样蛋白减少对认知变化的影响：一系列先验概率下的贝叶斯更新。
Alzheimers Dement. 2024 Feb;20(2):1149-1155. doi: 10.1002/alz.13470. Epub 2023 Oct 30.
3
Clinical trials in vascular cognitive impairment following SPRINT-MIND: An international perspective.
SPRINT-MIND 后血管性认知障碍的临床试验：国际视角。
Cell Rep Med. 2023 Jun 20;4(6):101089. doi: 10.1016/j.xcrm.2023.101089.
4
The structural and social determinants of Alzheimer's disease related dementias.阿尔茨海默病相关痴呆的结构和社会决定因素。
Alzheimers Dement. 2023 Jul;19(7):3171-3185. doi: 10.1002/alz.13027. Epub 2023 Apr 19.
5
A whole-population approach is required for dementia risk reduction.降低痴呆风险需要采取全人群方法。
Lancet Healthy Longev. 2022 Jan;3(1):e6-e8. doi: 10.1016/S2666-7568(21)00301-9.
6
Amyloid-Related Imaging Abnormalities and β-Amyloid-Targeting Antibodies: A Systematic Review.淀粉样蛋白相关成像异常与β淀粉样蛋白靶向抗体：一项系统综述。
JAMA Neurol. 2022 Mar 1;79(3):291-304. doi: 10.1001/jamaneurol.2021.5205.
7
Establishing a Framework for Gathering Structural and Social Determinants of Health in Alzheimer's Disease Research Centers.建立阿尔茨海默病研究中心健康结构和社会决定因素收集框架。
Gerontologist. 2022 May 26;62(5):694-703. doi: 10.1093/geront/gnab182.
8
What the Aducanumab Approval Reveals About Alzheimer Disease Research.阿杜卡努单抗获批对阿尔茨海默病研究的启示
JAMA Neurol. 2021 Nov 1;78(11):1305-1306. doi: 10.1001/jamaneurol.2021.3404.
9
Representativeness of Participants Eligible to Be Enrolled in Clinical Trials of Aducanumab for Alzheimer Disease Compared With Medicare Beneficiaries With Alzheimer Disease and Mild Cognitive Impairment.与患有阿尔茨海默病和轻度认知障碍的医疗保险受益人群相比，有资格参加阿杜卡奴单抗治疗阿尔茨海默病临床试验的参与者的代表性。
JAMA. 2021 Oct 26;326(16):1627-1629. doi: 10.1001/jama.2021.15286.
10
Twenty-seven-year time trends in dementia incidence in Europe and the United States: The Alzheimer Cohorts Consortium.27 年来欧洲和美国痴呆症发病率的时间趋势：阿尔茨海默病队列联盟。
Neurology. 2020 Aug 4;95(5):e519-e531. doi: 10.1212/WNL.0000000000010022. Epub 2020 Jul 1.